S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Stock market today: Asian shares gain despite Wall Street's tech-led retreat
Prologis Stock Leading U.S. Logistics Boom
CVE:GSD

Devonian Health Group (GSD) Stock Price, News & Analysis

C$0.22
-0.03 (-12.00%)
(As of 04/9/2024)
Today's Range
C$0.22
C$0.22
50-Day Range
C$0.13
C$0.25
52-Week Range
C$0.11
C$0.30
Volume
2,000 shs
Average Volume
17,184 shs
Market Capitalization
C$32.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Devonian Health Group

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, completed Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, the company acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. was incorporated in 2015 and is headquartered in Québec, Canada.

GSD Stock Price History

GSD Stock News Headlines

Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Devonian Health Group Inc.
Devonian Health Group Inc (GSD)
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
See More Headlines
Receive GSD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Devonian Health Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/18/2024
Next Earnings (Estimated)
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Net Income
C$-4,120,000.00
Net Margins
-128.59%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$3.21 million
Cash Flow
C$0.04 per share
Book Value
C$0.10 per share

Miscellaneous

Free Float
N/A
Market Cap
C$32.61 million
Optionable
Not Optionable
Beta
1.59
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Luc D. Gregoire CA (Age 64)
    CPA, President, CEO & Director
  • Ms. Colette Laurin C.A.
    CPA, Interim CFO, Corporate Secretary & Corporate Controller
  • Dr. Andre P. Boulet Ph.D. (Age 65)
    Chief Scientific Officer & Director
    Comp: $644.63k

GSD Stock Analysis - Frequently Asked Questions

How have GSD shares performed in 2024?

Devonian Health Group's stock was trading at C$0.15 at the start of the year. Since then, GSD stock has increased by 51.7% and is now trading at C$0.22.
View the best growth stocks for 2024 here
.

When is Devonian Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Sunday, June 30th 2024.
View our GSD earnings forecast
.

How do I buy shares of Devonian Health Group?

Shares of GSD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:GSD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners